Olfactory receptors like Olfr1089 are a subclass of G protein-coupled receptors (GPCRs), which are known for their roles in detecting volatile chemical odors. These receptors are located in the olfactory epithelium and initiate the olfactory signal transduction upon binding with specific odorant molecules. The signal transduction typically involves the activation of G proteins, which then activate adenylate cyclase, leading to an increase in intracellular cyclic AMP (cAMP). This cascade ultimately results in a neuronal response conveying the signal to the brain. The chemicals listed above are not specific inhibitors of Olfr1089 but are known to modulate various aspects of GPCR signaling pathways, which could indirectly affect the function of Olfr1089. For instance, compounds like Forskolin and KT5720 target the cAMP pathway, which is central to olfactory receptor signaling. Brefeldin A and Monensin affect intracellular trafficking and ion concentrations, respectively, which can influence the processing and functioning of GPCRs.
Tyrosine kinase inhibitors like Genistein, and PI3K inhibitors like Wortmannin and LY294002, can alter downstream signaling pathways linked to GPCR activity. Inhibitors of protein kinases such as PD98059, U73122, and Chelerythrine can modulate the phosphorylation status of proteins involved in GPCR-mediated signal transduction. NF449 specifically targets the Gs alpha subunit, which is directly involved in the signaling of olfactory receptors. Lastly, Clozapine N-oxide is used in a research context to control GPCR activity through DREADDs, offering a method to modulate GPCR function including that of olfactory receptors. These compounds provide valuable tools for research into the modulation of olfactory receptor activity, offering insights into the broader understanding of GPCR signaling and its regulation. While they do not inhibit Olfr1089 directly, their impact on related pathways and processes makes them relevant for studying the functional aspects of this and similar olfactory receptors.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts the structure and function of the Golgi apparatus, potentially affecting the post-translational processing and trafficking of olfactory receptors. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin is an ionophore that alters intracellular pH and ion concentrations, which can influence G protein-coupled receptor (GPCR) signaling pathways, including those of olfactory receptors. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that can modulate various signaling pathways, potentially impacting the phosphorylation state and function of GPCRs. | ||||||
KT 5720 | 108068-98-0 | sc-3538 sc-3538A sc-3538B | 50 µg 100 µg 500 µg | $138.00 $220.00 $972.00 | 47 | |
KT5720 is a potent inhibitor of protein kinase A (PKA), a key player in the cAMP-dependent pathway, often involved in olfactory receptor signaling. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent inhibitor of phosphoinositide 3-kinases (PI3K), which can modulate GPCR signaling pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 selectively inhibits MEK, which is involved in the MAPK/ERK pathway, potentially influencing GPCR-mediated signaling. | ||||||
Chelerythrine chloride | 3895-92-9 | sc-3547 sc-3547A | 5 mg 25 mg | $90.00 $317.00 | 17 | |
Chelerythrine is a potent inhibitor of protein kinase C (PKC), which is involved in various GPCR signaling pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a specific inhibitor of PI3K, modulating GPCR-related signaling. | ||||||
NF449 | 627034-85-9 | sc-478179 sc-478179A sc-478179B | 10 mg 25 mg 100 mg | $203.00 $469.00 $1509.00 | 1 | |
NF449 is a potent and selective inhibitor of Gs alpha subunit, a component of G protein involved in olfactory receptor signaling. | ||||||